In terms of a takeover, am I right in thinking we will get 2 phase 2 top-line results (P-Hopkins and Angelmans) within 2 weeks of each other in late March? Hard to see anything happening before that? That will be a pretty monumentous fortnight!! I think if they are both positive then NNZ-2591 will pretty much have proof of concept as a treatment in ASD. I attach a link to an interesting recent paper about, at least in part, aetiology of ASD. It really reinforces Neuren's strategy with ASD as an end-game, IMO.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915249/
In terms of a takeover, am I right in thinking we will get 2...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.73 |
Change
-0.280(1.33%) |
Mkt cap ! $2.647B | |||
| Open | High | Low | Value | Volume |
| $20.87 | $21.19 | $20.70 | $6.213M | 297.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5414 | $20.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.79 | 335 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.73 |
Change
-0.280 ( 1.22 %) |
||||
| Open | High | Low | Volume | ||
| $20.99 | $21.19 | $20.69 | 94423 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| NEU (ASX) Chart |